EUVIMEDEUVIMED entdecken
Crossref

Evaluation of the M371-Test Under Real-life Conditions for Diagnosis and Follow Up of Testicular Germ Cell Tumors

Stefan Pycha, Carolina D'Elia, Christine Mian, Christine Schwienbacher, Esther Hanspeter, Margherita Palermo, Armin Pycha, Hansjörg Danuser, Emanuela Trenti

Anticancer Research · 2023

DOI: 10.21873/anticanres.16316 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Stefan Pycha und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Testicular Neoplasms, Neoplasms, Germ Cell and Embryonal, Seminoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: The aim of the study was to establish the performance of the M371-Test on the Thermocycler Rotor-GeneQ (Qiagen) platform for diagnosis and follow-up of testicular tumors and to evaluate the test under real-life conditions in comparison to the classical markers alpha-fetoprotein (AFP), beta-human chorionic gonadotropin (β-HCG) and lactate dehydrogenase (LDH). PATIENTS AND METHODS: Forty-four patients, of median age 29 years (range=24-84) were included in this prospective study at our institution between March 2021 and September 2022. Of the 44 patients, 23 had a suspicion of testicular cancer (TC) and 21 were under follow-up for TC. In total, 96 M371-Tests were performed and compared with AFP, β-HCG, LDH using histological diagnosis and/or computer tomography (CT) scan as the gold standard. RESULTS: In the patients with suspicion of TC, the M371-Test showed a sensitivity of 73.7%, AFP of 21%, LDH of 31.6% and β-HCG of 42.1%. In the patients under follow-up for TC, the M371-Test showed a sensitivity of 86.4%, AFP of 50%, LDH of 31.8% and β-HCG of 63.6%. In germ cell tumours (GCT)/non-seminomas, M371-Test had a sensitivity of 83.3%, AFP of 77.8%, LDH of 38.9% and β-HCG of 66.7%. In GCT/seminomas, M371-Test had a sensitivity of 85%, AFP of 5%, LDH of 30% and β-HCG of 50%. CONCLUSION: Under real life conditions performed on the real-time Thermocycler Rotor-GeneQ (Qiagen) platform, the M371-Test shows an outstanding performance and is far beyond the sensitivity of the classical markers for detecting GCTs and in the follow-up of patients after GCT, especially in seminomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Testicular NeoplasmsNeoplasms, Germ Cell and EmbryonalSeminomaMaleHumansYoung AdultAdultMiddle AgedAgedAged, 80 and overalpha-FetoproteinsFollow-Up StudiesBiomarkers, TumorProspective StudiesChorionic Gonadotropin

Stichwörter der Autor:innen

Germ cell tumorsM371-testmiRNAtesticular

Substanzen

alpha-FetoproteinsBiomarkers, TumorChorionic Gonadotropin

Autor:innen und Institutionen

  • Faculty of Medicine, University of Bern, Bern, Switzerland.
  • Department of Urology, Provincial Hospital of Bolzano, Bolzano, Italy.
  • Department of Pathology, Provincial Hospital of Bolzano, Bolzano, Italy.
  • Faculty of Medicine, Latvia University, Riga, Latvia.
  • Sigmund Freud Private University, Vienna, Austria.
  • Department of Urology, Provincial Hospital of Bolzano, Bolzano, Italy; emanuela.trenti@sabes.it.

Zitieren

APA

Pycha, S., D'Elia, C., Mian, C., Schwienbacher, C., Hanspeter, E., Palermo, M., Pycha, A., Danuser, H., & Trenti, E. (2023). Evaluation of the M371-Test Under Real-life Conditions for Diagnosis and Follow Up of Testicular Germ Cell Tumors. Anticancer Research. https://doi.org/10.21873/anticanres.16316

Vancouver

Pycha S, D'Elia C, Mian C, Schwienbacher C, Hanspeter E, Palermo M, et al. Evaluation of the M371-Test Under Real-life Conditions for Diagnosis and Follow Up of Testicular Germ Cell Tumors. Anticancer Research. 2023. doi:10.21873/anticanres.16316

BibTeX
@article{Pycha2023,
  author = {Pycha, Stefan and D'Elia, Carolina and Mian, Christine and Schwienbacher, Christine and Hanspeter, Esther and Palermo, Margherita and Pycha, Armin and Danuser, Hansjörg and Trenti, Emanuela},
  title = {Evaluation of the M371-Test Under Real-life Conditions for Diagnosis and Follow Up of Testicular Germ Cell Tumors},
  journal = {Anticancer Research},
  year = {2023},
  doi = {10.21873/anticanres.16316}
}
Kostenlos starten →